SCHEMBL7180667

SCHEMBL7180667

O=C(NS(=O)(=O)O)C1CCCC1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC8 Q9BY41 1/20 0.52
HDAC6 Q9UBN7 1/20 0.52
EPHX1 P07099 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.42
HSD17B10 Q99714 1/20 0.42
CES2 O00748 1/20 0.42
CES1 P23141 1/20 0.42
NAAA Q02083 1/20 0.41
TSHR P16473 3/20 0.41
HSD11B1 P28845 2/20 0.41
MAPK1 P28482 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
MAPT P10636 1/20 0.39
HTT P42858 1/20 0.39
PTPN1 P18031 1/20 0.39
HPGD P15428 1/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
CA4 P22748 1/20 0.39
CA9 Q16790 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11139466 0.98 HDAC8 (0.56) HDAC8HDAC6EPHX1SMN1; SMN2HSD17B10
SCHEMBL11031178 0.83 HDAC8 (0.56) HDAC8HDAC6EPHX1SMN1; SMN2HSD17B10
SCHEMBL7695741 0.81 HDAC8 (0.48) HDAC8HDAC6EPHX1SMN1; SMN2HSD17B10
SCHEMBL15082184 0.81 HDAC8 (0.48) HDAC8HDAC6EPHX1SMN1; SMN2HSD17B10
SCHEMBL19060 0.79 HDAC8 (0.52) HDAC8HDAC6EPHX1SMN1; SMN2HSD17B10
SCHEMBL22169725 0.78 HDAC8 (0.50) HDAC8HDAC6EPHX1CES2CES1
SCHEMBL15931748 0.76 HDAC8 (0.43) HDAC8HDAC6EPHX1SMN1; SMN2HSD17B10
SCHEMBL22169769 0.76 HDAC8 (0.48) HDAC8HDAC6EPHX1SMN1; SMN2CES2
SCHEMBL22503052 0.76 HDAC8 (0.43) HDAC8HDAC6EPHX1SMN1; SMN2HSD17B10
SCHEMBL29633560 0.76 HDAC8 (0.43) HDAC8HDAC6EPHX1SMN1; SMN2HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6583130-B1 Substituted with acyl, oxycarbonyl, aminocarbonyl, sulfonyl, or aminosulfonyl; inhibit steroid sulfatase, do not exhibit any estrogenic effect and will not yield any estrogenic products on hydrolysis; treatment of estrogen-dependent tumors SCHERING AG (DE) 2003-06-24 US claimed
US-6583130-B1 Substituted with acyl, oxycarbonyl, aminocarbonyl, sulfonyl, or aminosulfonyl; inhibit steroid sulfatase, do not exhibit any estrogenic effect and will not yield any estrogenic products on hydrolysis; treatment of estrogen-dependent tumors SCHERING AG (DE) 2003-06-24 US disclosed